Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CooperVision Inc Company Overview 4
CooperVision Inc Company Snapshot 4
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CooperVision Inc – Pipeline Analysis Overview 6
CooperVision Inc – Key Facts 6
CooperVision Inc – Major Products and Services 7
CooperVision Inc Pipeline Products by Development Stage 8
CooperVision Inc Ongoing Clinical Trials by Trial Status 9
CooperVision Inc Pipeline Products Overview 11
Contact Lens 11
Contact Lens Product Overview 11
Contact Lens Clinical Trial 12
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Product Overview 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Clinical Trial 14
MyDay Toric – Plus Powers 15
MyDay Toric – Plus Powers Product Overview 15
CooperVision Inc – Key Competitors 16
CooperVision Inc – Key Employees 17
CooperVision Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
CooperVision Inc, Recent Developments 19
Jun 05, 2018: CooperVision Reveals EYEdea Lab at Optometry’s Meeting 2018; Best Practices Collaborate on the Future of the Profession with Harvard University Innovation Fellow 19
Mar 15, 2018: CooperVision Announces Availability of New MyDay toric in Plus Powers 19
Jan 23, 2018: CooperVision Creates Specialty Eye Care Business Unit, Names Juan Carlos Aragón as its President 20
Jan 02, 2018: CooperVision Introduces MyDay toric Daily Disposable Contact Lenses in the U.S 20
Dec 13, 2017: CooperVision Announces Nationwide Availability of Expanded Parameters for Avaira Vitality toric 21
Sep 13, 2017: LensFerry Now Offers EHR Integration; Automation Drives Practice Revenue 21
Sep 07, 2017: Together We’ve Made Biofinity Energys a Breakthrough Success 22
Jun 10, 2017: Three-year study says new contact lens therapy slows myopia progression in children by 59 percent 22
Jun 10, 2017: Three-Year Study Indicates Pioneering Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59% 23
Jun 05, 2017: CooperVision Receives Environmental Innovative Project of the Year, 12 Additional Environmental Sustainability and Occupational Health & Safety Honors 24
Appendix 25
Methodology 25
About GlobalData 28
Contact Us 28
Disclaimer 28
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CooperVision Inc Pipeline Products by Equipment Type 5
CooperVision Inc Pipeline Products by Indication 5
CooperVision Inc Ongoing Clinical Trials by Trial Status 5
CooperVision Inc, Key Facts 6
CooperVision Inc, Major Products and Services 7
CooperVision Inc Number of Pipeline Products by Development Stage 8
CooperVision Inc Pipeline Products Summary by Development Stage 8
CooperVision Inc Ongoing Clinical Trials by Trial Status 9
CooperVision Inc Ongoing Clinical Trials Summary 10
Contact Lens - Product Status 11
Contact Lens - Product Description 11
Contact Lens - Evaluation of Rexon-Eye Efficacy in Symptomatic Contact Lens Wearers and Dry Eye Sufferers 12
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses 14
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial 14
MyDay Toric - Plus Powers - Product Status 15
MyDay Toric - Plus Powers - Product Description 15
CooperVision Inc, Key Employees 17
Glossary 27
List of Figures
CooperVision Inc Pipeline Products by Equipment Type 5
CooperVision Inc Pipeline Products by Development Stage 8
CooperVision Inc Ongoing Clinical Trials by Trial Status 9